Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 19095997)

1.

Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosis.

MacDonald ML, van Eck M, Hildebrand RB, Wong BW, Bissada N, Ruddle P, Kontush A, Hussein H, Pouladi MA, Chapman MJ, Fievet C, van Berkel TJ, Staels B, McManus BM, Hayden MR.

Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):341-7. doi: 10.1161/ATVBAHA.108.181099. Epub 2008 Dec 18.

2.

Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice.

MacDonald ML, Singaraja RR, Bissada N, Ruddle P, Watts R, Karasinska JM, Gibson WT, Fievet C, Vance JE, Staels B, Hayden MR.

J Lipid Res. 2008 Jan;49(1):217-29. Epub 2007 Oct 24.

3.

Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice.

Zhang D, Fang P, Jiang X, Nelson J, Moore JK, Kruger WD, Berretta RM, Houser SR, Yang X, Wang H.

Circ Res. 2012 Jun 22;111(1):37-49. doi: 10.1161/CIRCRESAHA.112.269472. Epub 2012 May 24.

4.

Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.

Wilck N, Fechner M, Dreger H, Hewing B, Arias A, Meiners S, Baumann G, Stangl V, Stangl K, Ludwig A.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1418-26. doi: 10.1161/ATVBAHA.112.249342. Epub 2012 Apr 19.

5.

Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis.

Brown JM, Chung S, Sawyer JK, Degirolamo C, Alger HM, Nguyen T, Zhu X, Duong MN, Wibley AL, Shah R, Davis MA, Kelley K, Wilson MD, Kent C, Parks JS, Rudel LL.

Circulation. 2008 Sep 30;118(14):1467-75. doi: 10.1161/CIRCULATIONAHA.108.793182. Epub 2008 Sep 15.

6.

Overexpression of stearoyl-coenzyme A desaturase 1 in macrophages promotes reverse cholesterol transport.

Nakaya K, Ayaori M, Uto-Kondo H, Sotherden GM, Nishida T, Katamoto H, Miura Y, Takiguchi S, Yakushiji E, Iizuka M, Ogura M, Sasaki M, Yogo M, Komatsu T, Adachi T, Maruyama C, Ikewaki K.

Biochim Biophys Acta. 2013 Aug;1831(8):1402-11. doi: 10.1016/j.bbalip.2013.05.009. Epub 2013 Jun 6.

PMID:
23747827
7.

Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.

Babaev VR, Ishiguro H, Ding L, Yancey PG, Dove DE, Kovacs WJ, Semenkovich CF, Fazio S, Linton MF.

Circulation. 2007 Sep 18;116(12):1404-12. Epub 2007 Aug 27.

8.

Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.

Caravaggio JW, Hasu M, MacLaren R, Thabet M, Raizman JE, Veinot JP, Marcel YL, Milne RW, Whitman SC.

Cardiovasc Pathol. 2013 Nov-Dec;22(6):458-64. doi: 10.1016/j.carpath.2013.03.006. Epub 2013 May 17.

PMID:
23684818
9.

Macrophage adipose triglyceride lipase deficiency attenuates atherosclerotic lesion development in low-density lipoprotein receptor knockout mice.

Lammers B, Chandak PG, Aflaki E, Van Puijvelde GH, Radovic B, Hildebrand RB, Meurs I, Out R, Kuiper J, Van Berkel TJ, Kolb D, Haemmerle G, Zechner R, Levak-Frank S, Van Eck M, Kratky D.

Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):67-73. doi: 10.1161/ATVBAHA.110.215814. Epub 2010 Oct 28.

10.

Absence of stearoyl-CoA desaturase-1 does not promote DSS-induced acute colitis.

Macdonald ML, Bissada N, Vallance BA, Hayden MR.

Biochim Biophys Acta. 2009 Dec;1791(12):1166-72. doi: 10.1016/j.bbalip.2009.08.001. Epub 2009 Aug 17.

PMID:
19695343
11.

The role of stearoyl-CoA desaturase in obesity, insulin resistance, and inflammation.

Sampath H, Ntambi JM.

Ann N Y Acad Sci. 2011 Dec;1243:47-53. doi: 10.1111/j.1749-6632.2011.06303.x. Review.

PMID:
22211892
12.

Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis.

Brown JM, Chung S, Sawyer JK, Degirolamo C, Alger HM, Nguyen TM, Zhu X, Duong MN, Brown AL, Lord C, Shah R, Davis MA, Kelley K, Wilson MD, Madenspacher J, Fessler MB, Parks JS, Rudel LL.

Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):24-30. doi: 10.1161/ATVBAHA.109.198036. Epub 2009 Oct 15.

13.

Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.

Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P.

Circulation. 2003 Apr 1;107(12):1640-6. Epub 2003 Mar 24.

14.

KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.

Potì F, Gualtieri F, Sacchi S, Weißen-Plenz G, Varga G, Brodde M, Weber C, Simoni M, Nofer JR.

Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1505-12. doi: 10.1161/ATVBAHA.113.301347. Epub 2013 May 2.

15.

P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.

Stachon P, Peikert A, Michel NA, Hergeth S, Marchini T, Wolf D, Dufner B, Hoppe N, Ayata CK, Grimm M, Cicko S, Schulte L, Reinöhl J, von zur Muhlen C, Bode C, Idzko M, Zirlik A.

Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2237-45. doi: 10.1161/ATVBAHA.114.303585. Epub 2014 Aug 7.

PMID:
25104800
16.

Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice.

Thatcher SE, Zhang X, Howatt DA, Lu H, Gurley SB, Daugherty A, Cassis LA.

Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):758-65. doi: 10.1161/ATVBAHA.110.221614. Epub 2011 Jan 20.

17.

Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.

Schneider JG, Zhu Y, Coleman T, Semenkovich CF.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2699-706. Epub 2007 Oct 19. Erratum in: Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):e12.

18.

Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males.

Castellani LW, Chang JJ, Wang X, Lusis AJ, Reynolds WF.

J Lipid Res. 2006 Jul;47(7):1366-77. Epub 2006 Apr 25.

19.

Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice.

Choi JH, Jeon HJ, Park JG, Sonn SK, Lee MR, Lee MN, You HJ, Kim GY, Kim JH, Lee MH, Kwon OS, Nam KH, Kim HC, Jeong TS, Lee WS, Oh GT.

Atherosclerosis. 2010 Sep;212(1):146-52. doi: 10.1016/j.atherosclerosis.2010.05.003. Epub 2010 May 11.

PMID:
20684827
20.

Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice.

Teupser D, Kretzschmar D, Tennert C, Burkhardt R, Wilfert W, Fengler D, Naumann R, Sippel AE, Thiery J.

Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):2009-15. doi: 10.1161/ATVBAHA.108.175257. Epub 2008 Sep 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk